Cited by 209NF-κB Signaling PathwaysEstrogen and related hormone effectsSignaling Pathways in Disease

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2

Open access

Wang, Xiaobo, Belguise, Karine, Kersual, Nathalie, Kirsch, Kathrin H., Mineva, Nora D., Galtier, Florence, Chalbos, Dany, Sonenshein, Gail E.·2007·Nature Cell Biology

DOI 10.1038/ncb1559PMC PMC2394707

Open this paper in CoChat — free account

Abstract

Aberrant constitutive expression of c-Rel, p65 and p50 NF-kappaB subunits has been reported in over 90% of breast cancers. Recently, we characterized a de novo RelB NF-kappaB subunit synthesis pathway, induced by the cytomegalovirus (CMV) IE1 protein, in which binding of p50-p65 NF-kappaB and c-Jun-Fra-2 AP-1 complexes to the RELB promoter work in synergy to potently activate transcription. Although RelB complexes were observed in mouse mammary tumours induced by either ectopic c-Rel expression or carcinogen exposure, little is known about RelB in human breast disease. Here, we demonstrate constitutive de novo RelB synthesis is selectively active in invasive oestrogen receptor alpha (ERalpha)-negative breast cancer cells. ERalpha signalling reduced levels of functional NF-kappaB and Fra-2 AP-1 and inhibited de novo RelB synthesis, leading to an inverse correlation between RELB and ERalpha gene expression in human breast cancer tissues and cell lines. Induction of Bcl-2 by RelB promoted the more invasive phenotype of ERalpha-negative cancer cells. Thus, inhibition of de novo RelB synthesis represents a new mechanism whereby ERalpha controls epithelial to mesenchymal transition (EMT).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/ncb1559

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G. M., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M. A. M., Gelder, M. E. M., Yu, J. X., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,831
Metastasis: a question of life or death
Mehlen, P., & Puisieux, A. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1886 · Cited by 1,919
An Immunohistochemical Study
Isaacson, P. G., Doǧan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,913
bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
Sentman, C. L., Shutter, J. R., Hockenbery, D. M., Kanagawa, O., & Korsmeyer, S. J. (1991) · Cell · doi:10.1016/0092-8674(91)90361-2 · Cited by 1,188
NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21358 · Cited by 1,049
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat‐Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 818
Expression of relB is required for the development of thymic medulla and dendritic cells
Burkly, L. C., Hession, C. A., Ogata, L., Reilly, C. R., Marconi, L. A., Olson, D. L., Tizard, R., Gate, R., & Lo, D. D. (1995) · Nature · doi:10.1038/373531a0 · Cited by 781
Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.
Sovak, M. A., Bellas, R. E., Kim, D. W., Zanieski, G., Rogers, A. E., Traish, A. M., & Sonenshein, G. E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119848 · Cited by 720
Self-citation
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
Catz, S. D., & Johnson, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204926 · Cited by 538

Flagged first, then by citations

Show all 37 references

Sorted by citations

Chromosomal instability drives metastasis through a cytosolic DNA response
Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,593
The different roles of ER subtypes in cancer biology and therapy
Thomas, C. G., & Gustafsson, J.-Α. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3093 · Cited by 654
NF-κB and cancer — identifying targets and mechanisms
Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 647
Sex Differences in Autoimmune Disease from a Pathological Perspective
Fairweather, D., Frisancho-Kiss, S., & Rose, N. R. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071008 · Cited by 629
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Lee, S. T., Li, Z., Wu, Z., Aau, M., Guan, P., Karuturi, R. K. M., Liou, Y. C., & Yu, Q. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.011 · Cited by 412
The NF-κB activation pathways, emerging molecular targets for cancer prevention and therapy
Lin, Y., Bai, L., Chen, W., & Xu, S. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903431069 · Cited by 380
NF‐κB and epithelial to mesenchymal transition of cancer
Min, C., Eddy, S. F., Sherr, D. H., & Sonenshein, G. E. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21695 · Cited by 374
Self-citation
ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
Mak, P., Leav, I., Pursell, B. M., Bae, D., Yang, X., Taglienti, C. A., Gouvin, L. M., Sharma, V. M., & Mercurio, A. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.030 · Cited by 380
Inflammation: A driving force speeds cancer metastasis
Wu, Y., & Zhou, B. P. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9699 · Cited by 327
Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers
Sabbah, M., Emami, S., Redeuilh, G., Julien-Grille, S., Prevost, G. P., Zimber, A., Ouelaa-Benslama, R., Bracke, M., Wever, O. D., & Gespach, C. P. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.07.001 · Cited by 325
Estrogen and Cancer
Liang, J., & Shang, Y. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183708 · Cited by 336
Role of NF-κB in the skeleton
Novack, D. V. (2010) · Cell Research · doi:10.1038/cr.2010.159 · Cited by 319
Cancer metastasis: Mechanisms of inhibition by melatonin
Su, S., Hsieh, M., Yang, W., Chung, W., Reiter, R. J., & Yang, S. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12370 · Cited by 292
Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
Wang, W., Nag, S. A., & Zhang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106124315 · Cited by 287
MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways
Keklikoglou, I., Körner, C., Schmidt, C., Zhang, J. D., Heckmann, D., Shavinskaya, A., Allgayer, H., Gückel, B., Fehm, T. N., Schneeweiß, A., et al. (2011) · Oncogene · doi:10.1038/onc.2011.571 · Cited by 279
Non-canonical NF-κB Antagonizes STING Sensor-Mediated DNA Sensing in Radiotherapy
Hou, Y., Liang, H. L., Rao, E., Zheng, W., Huang, X., Deng, L., Zhang, Y., Yu, X., Xu, M. M., Mauceri, H. J., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.07.008 · Cited by 278
Regulation of gene expression by hypoxia
Kenneth, N. S., & Rocha, S. (2008) · Biochemical Journal · doi:10.1042/bj20081055 · Cited by 269
The NF-κB Pathway and Cancer Stem Cells
Rinkenbaugh, A. L., & Baldwin, A. S. (2016) · Cells · doi:10.3390/cells5020016 · Cited by 265
The immune system and inflammation in breast cancer
Jiang, X., & Shapiro, D. J. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.003 · Cited by 243
NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases
Sarkar, F. H., Li, Y., Wang, Z. P., & Kong, D. (2008) · International Reviews of Immunology · doi:10.1080/08830180802276179 · Cited by 234
Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells
Yang, J., Cao, Y., Sun, J., & Zhang, Y. (2009) · Medical Oncology · doi:10.1007/s12032-009-9344-3 · Cited by 219
New insights of epithelial-mesenchymal transition in cancer metastasis
Wu, Y., & Zhou, B. P. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2008.00443.x · Cited by 219
Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins
Popgeorgiev, N., Jabbour, L., & Gillet, G. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00013 · Cited by 208
A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-κB family
Vogel, C. F. A., & Matsumura, F. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.036 · Cited by 202
NF-κB, stem cells and breast cancer: the links get stronger
Shostak, K., & Chariot, A. (2011) · Breast Cancer Research · doi:10.1186/bcr2886 · Cited by 180
Chemokines: novel targets for breast cancer metastasis
Ali, S., & Lazennec, G. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9073-z · Cited by 182
The Human Cytomegalovirus Protein TRS1 Inhibits Autophagy via Its Interaction with Beclin 1
Chaumorcel, M., Lussignol, M., Mouna, L., Cavignac, Y., Fahie, K., Cotte-Laffitte, J., Geballe, A. P., Brune, W., Beau, I., Codogno, P., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05746-11 · Cited by 182
Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers
Baumgarten, S. C., & Frasor, J. M. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1302 · Cited by 173
Hyperactivated NF-κB and AP-1 Transcription Factors Promote Highly Accessible Chromatin and Constitutive Transcription across the Interleukin-6 Gene Promoter in Metastatic Breast Cancer Cells
Ndlovu, M. N., Lint, C. M. V., Wesemael, K. V., Callebert, P., Chalbos, D., Haegeman, G., & Berghe, W. V. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01657-08 · Cited by 153
Self-citation
Platelet-Derived Growth Factor-D Overexpression Contributes to Epithelial-Mesenchymal Transition of PC3 Prostate Cancer Cells
Kong, D., Wang, Z., Sarkar, S. H., Li, Y., Banerjee, S., Saliganan, A. D., Kim, H.-R. C., Cher, M. L., & Sarkar, F. H. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1076 · Cited by 160
Plumbagin‐induced apoptosis of human breast cancer cells is mediated by inactivation of NF‐κB and Bcl‐2
Ahmad, A., Banerjee, S., Wang, Z. P., Kong, D., & Sarkar, F. H. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21966 · Cited by 151
Positive Cross-Talk between Estrogen Receptor and NF-κB in Breast Cancer
Frasor, J. M., Weaver, A., Pradhan, M., Dai, Y., Miller, L. D., Lin, C., & Stanculescu, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2608 · Cited by 148
Gonadectomy of male BALB/c mice increases Tim-3+ alternatively activated M2 macrophages, Tim-3+ T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis
Frisancho-Kiss, S., Coronado, M. J., Frisancho, J. A., Lau, V. M., Rose, N. R., Klein, S. L., & Fairweather, D. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.12.002 · Cited by 143
miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β
Song, L., Huang, Q., Chen, K., Liu, L., Lin, C., Dai, T., Yu, C., Wu, Z., & Li, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.003 · Cited by 136
Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling
Qu, Y., Wang, J., Ray, P., Guo, H., Huang, J., Shin-Sim, M., Bukoye, B. A., Liu, B., Lee, A. V., Lin, X., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43144 · Cited by 128
Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS–cGAMP–STING Pathway
Ritchie, C., Carozza, J. A., & Li, L. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-101629 · Cited by 123
IKKα controls canonical TGFβ–SMAD signaling to regulate genes expressing SNAIL and SLUG during EMT in Panc1 cells
Brandl, M., Seidler, B., Haller, F., Adamski, J., Schmid, R. M., Saur, D., & Schneider, G. (2010) · Journal of Cell Science · doi:10.1242/jcs.071100 · Cited by 119
Non-apoptotic roles of Bcl-2 family: The calcium connection
Bonneau, B., Prudent, J., Popgeorgiev, N., & Gillet, G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.01.021 · Cited by 126
ERα, microRNAs, and the epithelial–mesenchymal transition in breast cancer
Reed, I. K. G., Adams, B. D., & White, B. A. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.12.001 · Cited by 112
Over‐expression of AEG‐1 significantly associates with tumour aggressiveness and poor prognosis in human non‐small cell lung cancer
Song, L., Li, W., Zhang, H., Liao, W., Dai, T., Yu, C., Ding, X., Zhang, L., & Li, J. (2009) · The Journal of Pathology · doi:10.1002/path.2595 · Cited by 112
ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis
Romagnoli, M., Mineva, N. D., Polmear, M. M., Conrad, C., Srinivasan, S. S., Loussouarn, D., Barillé‐Nion, S., Georgakoudi, I., Dagg, Á., McDermott, E. W. M., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201303373 · Cited by 112
Self-citation
Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway
Das, S., Becker, B. N., Hoffmann, F. M., & Mertz, J. E. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-94 · Cited by 109
Bcl-2 Family of Proteins in the Control of Mitochondrial Calcium Signalling: An Old Chap with New Roles
Morris, J. L., Gillet, G., Prudent, J., & Popgeorgiev, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073730 · Cited by 115
Epigallocatechin-3-Gallate Inhibits Stem-Like Inflammatory Breast Cancer Cells
Mineva, N. D., Paulson, K. E., Naber, S. P., Yee, A. S., & Sonenshein, G. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073464 · Cited by 103
Self-citation
Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer
Musgrove, E. A., Sergio, C. M., Loi, S., Inman, C. K., Anderson, L. R., Alles, M. C., Pinese, M., Caldon, C. E., Schütte, J., Gardiner‐Garden, M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002987 · Cited by 99
The interaction between ER and NFκB in resistance to endocrine therapy
Sas, L., Lardon, F., Vermeulen, P. B., Hauspy, J., van Dam, P. A., Pauwels, P., Dirix, L. Y., & Laere, S. V. (2012) · Breast Cancer Research · doi:10.1186/bcr3196 · Cited by 100
Inflammation Fuels Tumor Progress and Metastasis
Liu, J., Lin, P. C., & Zhou, B. P. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150514105741 · Cited by 103
Nuclear factor-κB signaling and ezrin are essential for L1-mediated metastasis of colon cancer cells
Gavert, N. S., Ben‐Shmuel, A., Lemmon, V., Brabletz, T., & Ben‐Ze'ev, A. (2010) · Journal of Cell Science · doi:10.1242/jcs.069542 · Cited by 99
Apoptosis‐inducing effect of garcinol is mediated by NF‐κB signaling in breast cancer cells
Ahmad, A., Wang, Z. P., Raza, A., Maitah, M. Y., Kong, D., Banerjee, S., Padhyé, S., & Sarkar, F. H. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22492 · Cited by 96
Epithelial-to-Mesenchymal Transition Induced by TGF-β1 Is Mediated by Blimp-1–Dependent Repression of BMP-5
Romagnoli, M., Belguise, K., Yu, Z., Wang, X., Landesman‐Bollag, E., Seldin, D. C., Chalbos, D., Barillé‐Nion, S., Jézéquel, P., Seldin, M. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2270 · Cited by 95
Self-citation
Epithelial-mesenchymal Transition and Its Role in the Pathogenesis of Colorectal Cancer
Zhu, Q., Gao, R., Wu, W., & Qin, H. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.5.2689 · Cited by 94
Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation
Voutsadakis, I. A. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5010011 · Cited by 94
Emerging roles of PDGF-D in EMT progression during tumorigenesis
Wu, Q., Hou, X., Xia, J., Qian, X., Miele, L., Sarkar, F. H., & Wang, Z. P. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.11.006 · Cited by 92
Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition
Tian, B., Li, X., Kalita, M. K., Widen, S. G., Yang, J., Bhavnani, S. K., Dang, B., Kudlicki, A. S., Sinha, M., Kong, F., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-1707-x · Cited by 88
Cancer Stem Cell-Like Phenotype and Survival Are Coordinately Regulated by Akt/FoxO/Bim Pathway
Gargini, R., Cerliani, J. P., Escoll, M., Antón, I. M., & Wandosell, F. G. (2014) · Stem Cells · doi:10.1002/stem.1904 · Cited by 86
The NF-κB Activating Pathways in Multiple Myeloma
Roy, P., Sarkar, U. A., & Basak, S. (2018) · Biomedicines · doi:10.3390/biomedicines6020059 · Cited by 85
BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?
Wang, L., & Di, L. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8579 · Cited by 87
ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
Thomas, C. G., Rajapaksa, G. K., Nikolos, F., Hao, R., Katchy, A., McCollum, C. W., Bondesson, M., Quinlan, P., Thompson, A. M., Krishnamurthy, S., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3358 · Cited by 80
The canonical NF-κB pathway is required for formation of luminal mammary neoplasias and is activated in the mammary progenitor population
Pratt, M. A. C., Tibbo, E., Robertson, S., Jansson, D., Hurst, K., Perez‐Iratxeta, C., Lau, R., & Niu, M. Y. (2009) · Oncogene · doi:10.1038/onc.2009.131 · Cited by 79
Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms
Chuffa, L. G. D. A., Reiter, R. J., & Lupi, L. A. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx054 · Cited by 78
Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells
Singh, S., & Chakrabarti, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050642 · Cited by 78
Panepoxydone Targets NF-kB and FOXM1 to Inhibit Proliferation, Induce Apoptosis and Reverse Epithelial to Mesenchymal Transition in Breast Cancer
Arora, R., Yates, C. C., Gary, B. D., McClellan, S. B., Tan, M., Xi, Y., Reed, E., Piazza, G. A., Owen, L. B., & Dean-Colomb, W. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098370 · Cited by 77
Retracted
Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications
Mimeault, M., & Batra, S. K. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.12.001 · Cited by 77
The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells
Belguise, K., Milord, S., Galtier, F., Moquet-Torcy, G., Piechaczyk, M., & Chalbos, D. (2012) · Oncogene · doi:10.1038/onc.2011.659 · Cited by 76
Self-citation
Estrogen Reduces Aldosterone, Upregulates Adrenal Angiotensin II AT2 Receptors and Normalizes Adrenomedullary Fra-2 in Ovariectomized Rats
Macova, M., Armando, I., Zhou, J., Baiardi, G., Tyurmin, D., Larrayoz-Roldan, I. M., & Saavedra, J. M. (2008) · Neuroendocrinology · doi:10.1159/000150977 · Cited by 75
Bone morphogenetic protein 7 induces mesenchymal‐to‐epithelial transition in melanoma cells, leading to inhibition of metastasis
Na, Y., Seok, S. H., Kim, D., Han, J., Kim, T., Jung, H. J., Lee, B., & Park, J. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01301.x · Cited by 78
Loss of ERα induces amoeboid-like migration of breast cancer cells by downregulating vinculin
Gao, Y., Wang, Z., Hao, Q., Li, W., Xu, Y., Zhang, J., Zhang, W., Wang, S., Liu, S., Li, M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14483 · Cited by 76
Bcl-2 Overexpression Induces a Partial Epithelial to Mesenchymal Transition and Promotes Squamous Carcinoma Cell Invasion and Metastasis
Zuo, J., Ishikawa, T., Boutros, S., Xiao, Z., Humtsoe, J. O., & Kramer, R. H. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0354 · Cited by 76
RelB NF-κB Represses Estrogen Receptor α Expression via Induction of the Zinc Finger Protein Blimp1
Wang, X., Belguise, K., O’Neill, C. F., Sánchez-Morgan, N., Romagnoli, M., Eddy, S. F., Mineva, N. D., Yu, Z., Min, C., Trinkaus‐Randall, V., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00032-09 · Cited by 72
Self-citation
PKCθ promotes c-Rel–driven mammary tumorigenesis in mice and humans by repressing estrogen receptor α synthesis
Belguise, K., & Sonenshein, G. E. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32424 · Cited by 71
Self-citation
NF-κB, Mesenchymal Differentiation and Glioblastoma
Yamini, B. (2018) · Cells · doi:10.3390/cells7090125 · Cited by 71
Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression
Vogel, C. F. A., Li, W., Wu, D., Miller, J. K., Sweeney, C. A., Lazennec, G., Fujisawa, Y., & Matsumura, F. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.05.011 · Cited by 68
The NF-κB RelB Protein Is an Oncogenic Driver of Mesenchymal Glioma
Lee, D. W., Ramakrishnan, D., Valenta, J., Parney, I. F., Bayless, K. J., & Sitcheran, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057489 · Cited by 70
The adhesion G protein-coupled receptor G2 (ADGRG2/GPR64) constitutively activates SRE and NFκB and is involved in cell adhesion and migration
Peeters, M. C., Fokkelman, M., Boogaard, B., Egerod, K. L., van de Water, B., IJzerman, A. P., & Schwartz, T. W. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.08.015 · Cited by 67
A Loss-of-Function Polymorphism in the Propeptide Domain of the LOX Gene and Breast Cancer
Min, C., Yu, Z., Kirsch, K. H., Zhao, Y., Vora, S. R., Trackman, P. C., Spicer, D. B., Rosenberg, L. A., Palmer, J. R., & Sonenshein, G. E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4818 · Cited by 70
Self-citation
The Apoptotic Regulator Nrz Controls Cytoskeletal Dynamics via the Regulation of Ca2+ Trafficking in the Zebrafish Blastula
Popgeorgiev, N., Bonneau, B., Ferri, K. F., Prudent, J., Thibaut, J., & Gillet, G. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.03.016 · Cited by 66
Withanolides-Induced Breast Cancer Cell Death Is Correlated with Their Ability to Inhibit Heat Protein 90
Wang, H., Tsai, Y.-L., Wu, Y., Chang, F., Liu, M.-H., Chen, W.-Y., & Wu, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037764 · Cited by 66
Molecular Markers of Epithelial-to-Mesenchymal Transition Are Associated with Tumor Aggressiveness in Breast Carcinoma
Sethi, S. N., Sarkar, F. H., Ahmed, Q. F., Bandyopadhyay, S., Nahleh, Z. A., Semaan, A. Y., Sakr, W., Munkarah, A. R., & Ali‐Fehmi, R. (2011) · Translational Oncology · doi:10.1593/tlo.10244 · Cited by 66
Diallyl Disulfide-Induced Apoptosis in a Breast-Cancer Cell Line (MCF-7) May Be Caused by Inhibition of Histone Deacetylation
Altonsy, M. O., Habib, T. N., & Andrews, S. C. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.721156 · Cited by 68
Noncanonical NF-κB in Cancer
Tegowski, M., & Baldwin, A. S. (2018) · Biomedicines · doi:10.3390/biomedicines6020066 · Cited by 73
The Lysyl Oxidase Pro-peptide Attenuates Fibronectin-mediated Activation of Focal Adhesion Kinase and p130Cas in Breast Cancer Cells
Zhao, Y., Min, C., Vora, S. R., Trackman, P. C., Sonenshein, G. E., & Kirsch, K. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802612200 · Cited by 65
Self-citation
The Emerging Function of PKCtheta in Cancer
Nicolle, A., Zhang, Y., & Belguise, K. (2021) · Biomolecules · doi:10.3390/biom11020221 · Cited by 64
Self-citation
Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies
Mimeault, M., & Batra, S. K. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.08.001 · Cited by 65
Gain of Oncogenic Function of p53 Mutants Induces Invasive Phenotypes in Human Breast Cancer Cells by Silencing CCN5/WISP-2
Dhar, G., Banerjee, S., Dhar, K., Tawfik, O. W., Mayo, M. S., VanVeldhuizen, P. J., & Banerjee, S. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0316 · Cited by 62
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
Zazzo, E. D., Galasso, G., Giovannelli, P., Donato, M. D., Bilancio, A., Perillo, B., Sinisi, A. A., Migliaccio, A., & Castoria, G. (2019) · Cancers · doi:10.3390/cancers11101418 · Cited by 62
NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms
Frasor, J. M., El-Shennawy, L., Stender, J. D., & Kastrati, I. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.09.013 · Cited by 61
Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α
Dou, X., Liang, Y., Lin, H., Wei, X., Zhang, Y., Bai, J., Chen, C., Chen, M., Du, C., Li, Y., et al. (2017) · Theranostics · doi:10.7150/thno.19989 · Cited by 62
Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer
Maharjan, C. K., Mo, J., Wang, L. A., Kim, M., Wang, S., Borcherding, N. C., Vikas, P., & Zhang, W. (2021) · Cancers · doi:10.3390/cancers14010206 · Cited by 63
Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment
Pires, B. R. B., de Amorim, Í. S. S., Souza, L. D. E., Rodrigues, J. A., & Mencalha, A. L. (2016) · Anticancer Research · doi:10.21873/anticanres.11151 · Cited by 60
Down-regulation of Forkhead box protein A1 (FOXA1) leads to cancer stem cell-like properties in tamoxifen-resistant breast cancer cells through induction of interleukin-6
Yamaguchi, N., Nakayama, Y., & Yamaguchi, N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.763276 · Cited by 58
RelB: an outlier in leukocyte biology
Millet, P., McCall, C. E., & Yoza, B. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0513305 · Cited by 57
Hypercapnia Induces Cleavage and Nuclear Localization of RelB Protein, Giving Insight into CO2 Sensing and Signaling
Oliver, K. M., Lenihan, C. R., Brüning, U., Cheong, A., Laffey, J. G., McLoughlin, P., Taylor, C. T., & Cummins, E. P. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347971 · Cited by 55
Modulation of oncogenic transcription factors by bioactive natural products in breast cancer
Hasanpourghadi, M., Pandurangan, A. K., & Mustafa, M. R. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.009 · Cited by 55
LncRNA DGCR5 plays a tumor-suppressive role in glioma via the miR-21/Smad7 and miR-23a/PTEN axes
He, Z., Long, J., Yang, C., Gong, B., Cheng, M., Wang, Q., & Tang, J. X. (2020) · Aging · doi:10.18632/aging.103800 · Cited by 52
TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion
Chevalier, C., Collin, G., Descamps, S., Touaitahuata, H., Simon, V., Reymond, N., Fernandez, L., Milhiet, P., Georget, V., Urbach, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10765 · Cited by 53
NFκB signaling is important for growth of antiestrogen resistant breast cancer cells
Yde, C. W., Emdal, K. B., Guerra, B., & Lykkesfeldt, A. E. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2053-1 · Cited by 51
Post-Translational Modifications of RelB NF-κB Subunit and Associated Functions
Baud, V., & Collares, D. (2016) · Cells · doi:10.3390/cells5020022 · Cited by 58
New advances on critical implications of tumor- and metastasis-initiating cells in cancer progression, treatment resistance and disease recurrence.
Mimeault, M., & Batra, S. K. (2010) · PubMed · doi:10.14670/hh-25.1057 · Cited by 49
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death
Narayanan, K. B., Ali, M., Barclay, B. J., Cheng, Q. S., D'Abronzo, L. S., Dornetshuber-Fleiss, R., Ghosh, P., Guzman, M. J. G., Lee, T. J., Leung, P. S., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv032 · Cited by 50
CD40 Ligand-mediated Activation of the de Novo RelB NF-κB Synthesis Pathway in Transformed B Cells Promotes Rescue from Apoptosis
Mineva, N. D., Rothstein, T. L., Meyers, J. A., Lerner, A., & Sonenshein, G. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607313200 · Cited by 47
Self-citation

Authors: Wang, X., Belguise, K., Kersual, N., Kirsch, K. H., Mineva, N. D., Galtier, F., Chalbos, D., & Sonenshein, G. E.
Affiliations: Boston University (US)
Inserm (FR)
Corresponding author: Sonenshein, Gail E.
ORCID: Wang, Xiaobo
Belguise, Karine
Kirsch, Kathrin H.
Mineva, Nora D.
Galtier, Florence
Chalbos, Dany
Sonenshein, Gail E.
Venue: Nature Cell Biology
Publisher: Springer Science and Business Media LLC
Published: 2007-03-18
Volume: 9
Issue: 4
Pages: 470-478
ISSN: 1465-7392 (ISSN-L)
1476-4679
DOI: 10.1038/ncb1559
PMC: PMC2394707
OpenAlex: W2112528220
Cited by: 209
References: 37
Citations by year: 2026: 1 · 2025: 2 · 2024: 2 · 2023: 7 · 2022: 5 · 2021: 9 · 2020: 5 · 2019: 7 · 2018: 10 · 2017: 9 · 2016: 12 · 2015: 13 · 2014: 11 · 2013: 18 · 2012: 22
FWCI: 7.19
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Cell Biology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
HAL (submittedVersion, other-oa)
Funders: National Cancer Institute (R01CA036355, CA 36355)
National Institute of Environmental Health Sciences (ES 11624, P01ES011624)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
Keywords: RelB, NF-κB, estrogen receptor alpha, breast cancer, tumor invasion, epithelial-mesenchymal transition, Bcl-2, c-Rel, transcriptional regulation
MeSH terms: Animals, Breast Neoplasms, Cell Movement, Cell Transformation, Neoplastic, Estrogens, Female, Humans, Microscopy, Fluorescence, Phenotype, Protein Binding, Immunoblotting, Blotting, Northern, Signal Transduction, Gene Expression Regulation, Neoplastic, NF-kappa B, Proto-Oncogene Proteins c-bcl-2, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Cell Line, Tumor, Estrogen Receptor alpha, Mice, Transcription Factor RelB, Fos-Related Antigen-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks